Eric Langer has over 25 years experience in biotechnology and life sciences international marketing, management, market assessment, valuation and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies in downstream bioprocessing, and blood products. He is an experienced biotechnology strategist and marketing practitioner; he and his team have advised 100s of companies on marketing strategy development, pricing and message strategy, and have developed marketing plans based on quantitative analysis of market trends and buyer needs.
In 1989 he co-founded BioPlan Associates, Inc. a biotechnology and life sciences marketing company that provides information, market research, valuation services, pricing strategy, and market analysis to biotechnology and healthcare organizations. He has launched and managed marketing programs for product lines ranging from $500k to $500 million. His company works with both large and small clients at commercial biotechs, non-profit organizations, and governments in assessing and evaluating markets, and marketing strategies and tactics.